New England Capital Financial Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$81.5K Sell
788
-97
-11% -$8.66K 0.02% 104
2026
Q1
$63.5K Buy
885
+5
+0.6% +$385 0.02% 115
2025
Q4
$69.8K Sell
880
-96
-10% -$7.57K 0.03% 110
2025
Q3
$73.6K Buy
976
+5
+0.5% +$343 0.03% 100
2025
Q2
$67K Buy
971
+315
+48% +$20.7K 0.03% 100
2025
Q1
$44.4K Sell
656
-43
-6% -$2.57K 0.02% 117
2024
Q4
$31.4K Sell
699
-28
-4% -$1.57K 0.02% 145
2024
Q3
$45.7K Buy
727
+40
+6% +$2.33K 0.02% 117
2024
Q2
$40.6K Buy
687
+130
+23% +$8.13K 0.02% 124
2024
Q1
$44.4K Sell
557
-1,939
-78% -$148K 0.03% 117
2023
Q4
$197K Sell
2,496
-12
-0.5% -$854 0.12% 52
2023
Q3
$175K Buy
2,508
+19
+0.8% +$1.35K 0.12% 53
2023
Q2
$172K Sell
2,489
-131
-5% -$9.32K 0.11% 57
2023
Q1
$195K Buy
2,620
+16
+0.6% +$1.34K 0.14% 52
2022
Q4
$227K Buy
+2,604
New +$251K 0.16% 51

Other funds holding CVS

New England Capital Financial Advisors's CVS Position: Q2 2026 in Review

New England Capital Financial Advisors reduced its CVS Health (CVS) stake by 11% in Q2 2026, selling an estimated $8.66K and leaving 788 shares worth $81.5K. The position accounts for 0.02% of the portfolio, ranked #104.

New England Capital Financial Advisors first reported a position in CVS in Q4 2022 and has held it in 15 quarters since. The position peaked at $227K in Q4 2022. 937 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • New England Capital Financial Advisors held 788 shares of CVS Health worth $81.5K as of Q2 2026.
  • New England Capital Financial Advisors sold 97 CVS Health shares in Q2 2026, an estimated $8.66K.
  • CVS Health made up 0.02% of New England Capital Financial Advisors's portfolio in Q2 2026, its #104 holding.
  • New England Capital Financial Advisors first reported a position in CVS Health in Q4 2022 and has held it in 15 quarters since.
  • New England Capital Financial Advisors's CVS Health position peaked at $227K in Q4 2022.
  • 937 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on New England Capital Financial Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.